Thermo Fisher Scientific Inc.

TMO ·Technology, Scientific & Technical Instruments, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $45.00B $42.86B $42.87B $44.92B $39.22B $32.21B $25.54B $24.36B
Life Sciences Solutions $10.35B $9.82B $9.98B $13.53B $15.63B $12.17B $6.86B $6.27B
Analytical Instruments $7.82B $7.41B $7.26B $6.62B $6.07B $5.12B $5.52B $5.44B
Specialty Diagnostics $4.68B $4.48B $4.40B $4.76B $5.62B $5.34B $3.71B $3.72B
Laboratory Products and Services $22.15B $21.15B $21.23B $20.00B $11.90B $9.58B $9.45B $8.93B
Cost of Revenue — — — — — — — —
Gross Profit — — — — — — — —
Gross Margin — — — — — — — —
Operating Expenses
Research & Development $1.40B $1.39B $1.34B $1.47B $1.41B $1.18B $1.00B $967.0M
SG&A Expense $8.73B $8.60B $8.45B $8.99B $8.01B $6.93B $6.14B $6.06B
Operating Income $7.75B $7.34B $6.86B $8.39B $10.03B $7.79B $4.59B $3.78B
Operating Margin 17.2% 17.1% 16.0% 18.7% 25.6% 24.2% 18.0% 15.5%
Interest Expense — — $1.38B $726.0M $536.0M $553.0M $676.0M $667.0M
Pretax Income $7.31B $7.04B $6.30B $7.84B $8.84B $7.23B $4.07B $3.26B
Income Tax Expense $547.0M $657.0M $284.0M $703.0M $1.11B $850.0M $374.0M $324.0M
Net Income $6.70B $6.34B $6.00B $6.96B $7.73B $6.38B $3.70B $2.94B
Net Margin 14.9% 14.8% 14.0% 15.5% 19.7% 19.8% 14.5% 12.1%
EPS (Basic) $17.77 $16.58 $15.52 $17.75 $19.62 $16.09 $9.24 $7.31
EPS (Diluted) $17.74 $16.53 $15.45 $17.63 $19.46 $15.96 $9.17 $7.24
Shares Outstanding (Basic) 377.0M 382.0M 386.0M 392.0M 394.0M 396.0M 400.0M 402.0M
Shares Outstanding (Diluted) 378.0M 383.0M 388.0M 394.0M 397.0M 399.0M 403.0M 406.0M
Dividends Per Share $1.72 $1.56 $1.40 $1.20 $1.04 $0.88 $0.76 $0.68
← Newer Page 1 of 3 Older →